Tao Ren, PhD

Dr. Tao Ren has two decades of experience in drug-screening model development, organoid and primary tumor cell culture, and high-throughput screening platform construction. He has led national and regional R&D initiatives and previously served as a professor at the Hefei Institutes of Physical Science, Chinese Academy of Sciences. His work supports the development of advanced cell-based platforms for precision drug evaluation.

▪ 20+ years of experience in drug-screening and cell-based technologies

▪ Leadership of national and provincial R&D programs

▪ Ph.D., University of Nebraska-Lincoln

▪ Postdoctoral Fellow, Harvard Medical School